We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi, Regeneron Allowed to Sell Cholesterol Drug, Pending an Appeal on Injunction
Sanofi, Regeneron Allowed to Sell Cholesterol Drug, Pending an Appeal on Injunction
A federal appeals court temporarily suspended a permanent injunction that bars Sanofi and Regeneron from selling their cholesterol drug Praluent, pending a final ruling on an appeal.